玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
24Q3 (20)472.172.170.07187.5333.330.04144.44300.00.1677.78-30.430.9716.87-10.1961.48-0.443.52.38153.72326.673.37180.82353.380.02150.0300.00.03200.0400.03.01182.47304.763.37180.82353.38-6.3920.22-4.25
24Q2 (19)460.00.0-0.08-147.06-166.67-0.09-152.94-181.820.09-47.06-65.380.83-29.66-24.5561.754.55-4.96-4.43-172.39-183.11-4.17-165.05-183.9-0.04-157.14-166.67-0.03-137.5-160.0-3.65-157.3-165.41-4.17-165.05-183.9-14.40-70.41-76.47
24Q1 (18)460.00.00.176.2521.430.170.013.330.17-56.4121.431.180.85-5.659.06-10.220.316.12-22.9218.66.413.7223.510.07-22.2216.670.0814.2933.336.37-11.0344.446.413.7223.514.59319.79475.00
23Q4 (17)460.00.00.16633.33-52.940.17950.0-46.880.3969.57-70.01.178.33-12.6965.7810.741.297.94856.19-33.056.18564.66-46.540.091000.0-43.750.07800.0-53.337.16587.07-38.966.18564.66-46.543.25254.17415.91
23Q3 (16)460.00.0-0.03-125.0-115.0-0.02-118.18-111.760.23-11.54-76.041.08-1.82-11.4859.40-8.57-5.4-1.05-119.7-117.5-1.33-126.76-117.85-0.01-116.67-114.29-0.01-120.0-111.11-1.47-126.34-120.5-1.33-126.76-117.85-6.91-69.64-72.43
23Q2 (15)460.00.00.12-14.29-45.450.11-26.67-52.170.2685.71-65.791.1-12.0-11.2964.9710.34-0.65.333.29-37.074.97-4.24-38.790.060.0-40.00.05-16.67-50.05.5826.53-29.284.97-4.24-38.79-9.36-36.55-39.89
23Q1 (14)460.00.00.14-58.82-74.070.15-53.12-70.590.14-89.23-74.071.25-6.72-16.1158.88-9.33-4.825.16-56.49-68.715.19-55.1-68.870.06-62.5-76.00.06-60.0-76.04.41-62.4-73.815.19-55.1-68.871.565.5917.56
22Q4 (13)460.00.00.3470.0-40.350.3288.24-39.621.3035.4227.451.349.84-17.7964.943.425.6511.8697.67-27.5911.5655.17-27.30.16128.57-40.740.1566.67-42.3111.7363.6-30.1811.5655.17-27.34.1230.4531.07
22Q3 (12)460.00.00.20-9.09-55.560.17-26.09-57.50.9626.32113.331.22-1.61-23.2762.79-3.937.416.00-29.16-49.457.45-8.25-42.740.07-30.0-63.160.09-10.0-57.147.17-9.13-44.637.45-8.25-42.74-9.20-34.17-40.49
22Q2 (11)460.00.00.22-59.26-15.380.23-54.921.050.7640.7401.24-16.78-8.8265.365.668.438.47-48.6421.358.12-51.29-7.410.1-60.00.00.1-60.0-16.677.89-53.15-16.68.12-51.29-7.41-12.69-32.26-29.34
22Q1 (10)460.00.00.54-5.26307.690.51-3.77296.150.54-47.06307.691.49-8.5931.8661.860.6311.0416.490.67252.8316.674.84257.120.25-7.41308.330.25-3.85308.3316.840.24256.816.674.84257.12-3.0410.7114.37
21Q4 (9)460.00.00.5726.67296.550.5332.5289.291.02126.67190.271.632.5248.1861.475.157.6516.3837.99224.1815.9022.21231.730.2742.11280.00.2623.81300.016.8029.73231.0515.9022.21231.739.7149.8871.52
21Q3 (8)460.00.00.4573.08212.50.40110.53205.260.450153.571.5916.9165.6258.46-3.02-5.2211.8770.06168.2213.0148.35168.580.1990.0211.760.2175.0216.6712.9536.89173.2513.0148.35168.5818.63136.54141.81
21Q2 (7)460.00.00.26200.0166.670.19173.08142.220.00100.0100.01.3620.3530.7760.288.26.846.98164.69137.678.77182.66150.550.1183.33152.630.12200.0166.679.46188.08160.648.77182.66150.5511.54105.1790.11
21Q1 (6)460.00.0-0.2610.34-420.0-0.267.14-1200.0-0.2676.99-420.01.132.73-6.6155.71-2.43-5.32-10.7918.2-7607.14-10.6112.1-516.86-0.1220.00-0.127.69-500.0-10.7416.22-913.21-10.6112.1-516.868.6518.9216.73
20Q4 (5)460.00.0-0.2927.5-203.57-0.2826.32-200.0-1.13-34.52-10.781.114.58-16.0357.10-7.43-5.68-13.1924.2-241.52-12.0736.37-225.08-0.1511.76-225.0-0.1327.78-200.0-12.8227.49-239.35-12.0736.37-225.08--0.00
20Q3 (4)460.00.0-0.40-2.560.0-0.3815.560.0-0.84-90.910.00.96-7.690.061.689.320.0-17.406.10.0-18.97-9.340.0-0.1710.530.0-0.180.00.0-17.68-13.330.0-18.97-9.340.0--0.00
20Q2 (3)460.00.0-0.39-680.00.0-0.45-2150.00.0-0.44-780.00.01.04-14.050.056.42-4.110.0-18.53-13135.710.0-17.35-908.720.0-0.1900.0-0.18-800.00.0-15.60-1371.70.0-17.35-908.720.0--0.00
20Q1 (2)460.00.0-0.05-117.860.0-0.02-107.140.0-0.0595.10.01.21-7.630.058.84-2.810.0-0.14-101.50.0-1.72-117.820.00-100.00.0-0.02-115.380.0-1.06-111.520.0-1.72-117.820.0--0.00
19Q4 (1)460.00.00.280.00.00.280.00.0-1.020.00.01.310.00.060.540.00.09.320.00.09.650.00.00.120.00.00.130.00.09.200.00.09.650.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/100.29-2.72-35.213.23-16.210.92N/A-
2024/90.3-7.47-14.02.93-13.680.970.65-
2024/80.33-6.25-9.222.63-13.640.920.68-
2024/70.3538.93-4.292.31-14.230.890.7-
2024/60.25-15.99-38.611.96-15.780.830.85-
2024/50.34.52-23.041.71-10.940.850.84-
2024/40.287.22-8.91.41-7.890.860.82-
2024/30.27-15.07-32.51.13-7.631.130.63-
2024/20.31-43.17-8.260.864.171.230.58-
2024/10.5550.0612.870.5512.871.280.55-
2023/120.371.08-13.24.58-13.941.180.64-
2023/110.36-19.79-30.724.21-14.011.170.65-
2023/100.4529.118.043.85-12.011.160.65-
2023/90.35-2.33-4.663.4-14.131.070.79-
2023/80.36-1.16-23.243.05-15.11.130.75-
2023/70.36-10.89-4.022.69-13.881.160.73-
2023/60.415.310.412.33-15.241.110.87-
2023/50.3923.73-0.621.92-17.951.090.88-
2023/40.31-20.55-28.371.53-21.411.050.92-
2023/30.3915.42-15.841.22-19.41.220.84-
2023/20.34-30.08-24.470.83-20.991.250.82-
2023/10.4915.39-18.360.49-18.361.430.72-
2022/120.42-19.32-8.375.32-6.561.360.7-
2022/110.5225.09-8.194.9-6.41.310.73-
2022/100.4213.92-29.484.38-6.181.250.76-
2022/90.37-21.36-29.313.96-2.781.210.8-
2022/80.4723.58-17.143.591.091.250.78-
2022/70.38-6.77-23.23.124.531.170.83-
2022/60.414.23-33.332.7510.01.230.69-
2022/50.39-10.823.692.3423.961.290.66-
2022/40.44-6.6610.621.9528.991.360.63-
2022/30.473.585.861.5235.471.520.44-
2022/20.45-24.4281.041.0554.771.510.44本公司提升免疫力產品,受疫情影響銷量增加,及代理巿場熱門石墨烯商品,導致營收增加。
2022/10.629.539.470.639.471.630.41-
2021/120.46-19.164.285.732.891.620.38-
2021/110.57-3.959.445.2436.181.680.36防疫期間新品上市與提升免疫產品銷量增加,導致營收較去年同期增加
2021/100.5914.1886.364.6733.791.680.36防疫期間新品上市與提升免疫產品銷量增加,導致營收較去年同期增加
2021/90.52-7.8273.314.0728.511.580.41防疫期間消費者透過電視、網路購物比重提高,及新品上市與提升免疫產品銷量增加,導致營收較去年同期增加
2021/80.5614.5584.733.5523.821.660.38防疫期間消費者透過電視、網路購物比重提高,及新品上市,導致營收較去年同期增加
2021/70.49-19.0754.592.9916.571.480.43受疫情影響,提升免疫產品銷量大幅增加。
2021/60.6162.1192.642.511.181.380.45受疫情影響,防疫產品銷量大幅增加。
2021/50.38-4.85-1.631.89-2.141.210.51-
2021/40.39-10.6810.091.51-2.261.090.57-
2021/30.4477.1521.231.12-5.981.120.46-
2021/20.25-41.77-38.710.68-17.991.120.46-
2021/10.43-3.172.110.432.111.230.42-
2020/120.4423.59-15.424.29-1.351.120.47-
2020/110.3612.31-15.33.850.560.980.54-
2020/100.326.19-20.193.492.530.920.57-
2020/90.3-1.752.993.175.550.920.58-
2020/80.31-4.1322.172.875.830.940.57-
2020/70.320.84-15.812.564.171.020.53-
2020/60.32-17.224.152.257.791.060.51-
2020/50.386.48-2.31.938.421.10.49-
2020/40.36-1.6413.891.5511.431.130.48-
2020/30.36-10.4416.751.1910.711.190.53-
2020/20.41-2.9849.680.838.241.350.47-
2020/10.42-19.8-14.670.42-14.671.360.46-
2019/120.5223.7650.184.35-18.440.0N/A新品上市,致本月銷售金額增加。
2019/110.425.83-31.013.82-23.240.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)460.00.39-70.00.43-65.044.6-13.0462.21-2.314.44-59.753.85-65.780.2-65.520.18-69.490.18-69.49
2022 (9)460.01.3027.451.2341.385.29-7.3663.687.5511.0346.6811.2537.870.5834.880.5920.410.5925.53
2021 (8)460.01.0200.8705.7132.4859.211.37.5208.1600.4300.4900.470
2020 (7)460.0-1.130-1.1504.31-1.1558.45-1.57-11.760-11.980-0.510-0.490-0.520
2019 (6)460.0-1.020-1.0404.36-18.3559.3812.7-9.960-10.730-0.430-0.420-0.470
2018 (5)460.0-2.070-1.3405.343.6952.696.08-12.190-17.770-0.650-0.960-0.940
2017 (4)460.0-4.450-4.2805.15-31.8849.67-16.79-37.920-39.480-1.950-1.970-2.030
2016 (3)460.0-1.170-0.6607.56-10.1159.69-6.27-4.270-7.060-0.320-0.540-0.530
2015 (2)460.01.07-20.151.26-13.18.41-0.3663.684.918.72-11.655.84-19.890.73-12.050.63-17.110.49-19.67
2014 (1)460.01.3425.231.4511.548.44-8.0660.7009.8707.2900.839.210.7618.750.6124.49

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。